Cargando…

Dexamethasone/remdesivir: Derangement of liver function tests, pneumocystis pneumonia and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051779/ http://dx.doi.org/10.1007/s40278-022-14117-y

Ejemplares similares

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/favipiravir/metoclopramide: Sinus bradycardia, deranged liver enzymes and off-label use: case report
Publicado: (2021)

Apixaban/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Sinus bradycardia and off label use in COVID-19 and :case report
Publicado: (2021)

Dexamethasone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)

Dexamethasone: Pneumocystis jirovecii pneumonia and methicillin-resistant Staphylococcus aureus endocarditis following the off-label use: 2 case reports
Publicado: (2022)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Dexamethasone/insulin/remdesivir: Lack of drug effect and off label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir/rituximab: Hypotension, dyspnoea and lack of efficacy following off-label use: case report
Publicado: (2021)

Betamethasone/dexamethasone/prednisone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/warfarin interaction: Elevation of international normalised ratio and off-label use: 2 case reports
Publicado: (2021)

Antithymocyte-globulin/dexamethasone/remdesivir: COVID-19, lack of efficacy and off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report
Publicado: (2022)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Isavuconazole/letermovir/remdesivir: Drug-induced liver injury and off-label use: case report
Publicado: (2021)

Remdesivir: Renal dysfunction and liver dysfunction following off-label use: 2 case reports
Publicado: (2022)

Methylprednisolone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Multiple drugs: Pneumocystis jirovecii pneumonia and lack of efficacy following an off-label treatment: 5 case reports
Publicado: (2021)

Dexamethasone/remdesivir: Acute pancreatitis: case report
Publicado: (2022)

Lopinavir/ritonavir/remdesivir: Drug induced liver injury and off label use: 5 case reports
Publicado: (2020)

Remdesivir: Liver function test increased: case report
Publicado: (2022)

Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021)

Amiodarone/chloroquine/remdesivir interaction: Hepatotoxicity and off-label therapy: case report
Publicado: (2021)

Antibacterials/interferon/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/propofol/remdesivir: Various toxicities: case report
Publicado: (2021)

Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mfcojqm3vse0hdftd1cgtr4cs4